Featuring perspectives from Dr Shilpa Gupta and Dr Jonathan E Rosenberg, including the following topics:

• Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Gupta (0:00)
• Optimizing the Treatment of Metastatic UBC — Dr Rosenberg (21:52)

CME information and select publications

Featuring perspectives from Dr Paul E Oberstein and Dr Philip A Philip, including the following topics:

• Selection and Sequencing of Therapy for Patients with Metastatic Pancreatic Adenocarcinoma (PAD) — Dr Oberstein (0:00)
• Biomarker-Based Strategies for Metastatic PAD; Novel Investigational Approaches — Dr Philip(30:57)

CME information and select publications

Featuring an interview with Dr Jennifer Crombie, including the following topics:

• Overview of similarities and differences among CD20 x CD3 targeted bispecific antibodies for the treatment of lymphomas (0:00)
• Optimal integration of CD20 x CD3 bispecific antibodies into treatment algorithms for lymphomas (9:40)
• Case: A man in his late 60s with relapsed follicular lymphoma (FL) who received mosunetuzumab (23:52)
• Case: A man in his late 80s with transformed, double-hit diffuse large B-cell lymphoma (DLBCL) who received epcoritamab (28:46)
• Case: A woman in her early 70s with recurrent FL who received odronextamab on the ELM-1 trial (34:06)
• Case: A man in his early 80s with multiregimen-relapsed DLBCL who receives glofitamab (43:19)

CME information and select publications